Mechanism of action of hypoglycemic effects of an intestine-specific inhibitor of microsomal triglyceride transfer protein (MTP) in obese rats

Diminished insulin sensitivity in the peripheral tissues and failure of pancreatic beta cells to secrete insulin are known major determinants of type 2 diabetes mellitus. jtt-130,an intestine-specific microsomal transfer protein inhibitor,has been shown to suppress high fat-induced obesity and ameliorate impaired glucose tolerance while enhancing glucagon-like peptide-1 (glp-1) secretion. we investigated the effects of jtt-130 on glucose metabolism and elucidated the mechanism of action,direct effects on insulin sensitivity and glucose-stimulated insulin secretion in a high fat diet-induced obesity rat model. male sprague dawley rats fed a high-fat diet were treated with a single administration of jtt-130. glucose tolerance,hyperglycemic clamp and hyperinsulinemic-euglycemic testing were performed to assess effects on insulin sensitivity and glucose-stimulated insulin secretion,respectively. plasma glp-1 and tissue triglyceride content were also determined under the same conditions. a single administration of jtt-130 suppressed plasma glucose elevations after oral glucose loading and increased the disposition index while elevating glp-1. jtt-130 also enhanced glucose-stimulated insulin secretion in hyperglycemic clamp tests,whereas increased insulin sensitivity was observed in hyperinsulinemic-euglycemic clamp tests. single-dose administration of jtt-130 decreased lipid content in the liver and skeletal muscle. jtt-130 demonstrated acute and direct hypoglycemic effects by enhancing insulin secretion and/or insulin sensitivity. © 2014 japanese pharmacological society.